JP5424401B2 - 反芻動物の鼓脹症防除剤 - Google Patents
反芻動物の鼓脹症防除剤 Download PDFInfo
- Publication number
- JP5424401B2 JP5424401B2 JP2009517919A JP2009517919A JP5424401B2 JP 5424401 B2 JP5424401 B2 JP 5424401B2 JP 2009517919 A JP2009517919 A JP 2009517919A JP 2009517919 A JP2009517919 A JP 2009517919A JP 5424401 B2 JP5424401 B2 JP 5424401B2
- Authority
- JP
- Japan
- Prior art keywords
- cashew nut
- nut shell
- bloating
- feed
- shell liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000282849 Ruminantia Species 0.000 title claims description 19
- 206010000060 Abdominal distension Diseases 0.000 title description 41
- 208000024330 bloating Diseases 0.000 title description 41
- 244000226021 Anacardium occidentale Species 0.000 claims description 53
- 235000020226 cashew nut Nutrition 0.000 claims description 52
- 239000007788 liquid Substances 0.000 claims description 42
- 239000003795 chemical substances by application Substances 0.000 claims description 24
- 241000194049 Streptococcus equinus Species 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 16
- 235000014398 anacardic acid Nutrition 0.000 claims description 8
- KAOMOVYHGLSFHQ-UTOQUPLUSA-N anacardic acid Chemical compound CCC\C=C/C\C=C/CCCCCCCC1=CC=CC(O)=C1C(O)=O KAOMOVYHGLSFHQ-UTOQUPLUSA-N 0.000 claims description 7
- ADFWQBGTDJIESE-UHFFFAOYSA-N anacardic acid 15:0 Natural products CCCCCCCCCCCCCCCC1=CC=CC(O)=C1C(O)=O ADFWQBGTDJIESE-UHFFFAOYSA-N 0.000 claims description 7
- 208000010444 Acidosis Diseases 0.000 claims description 6
- 230000007950 acidosis Effects 0.000 claims description 6
- 208000026545 acidosis disease Diseases 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 208000003495 Coccidiosis Diseases 0.000 claims description 3
- 206010023076 Isosporiasis Diseases 0.000 claims description 3
- 210000004767 rumen Anatomy 0.000 description 16
- 230000000694 effects Effects 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 241001494479 Pecora Species 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 231100000676 disease causative agent Toxicity 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 102000011632 Caseins Human genes 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- -1 Glycerin fatty acid ester Chemical class 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- KVVSCMOUFCNCGX-UHFFFAOYSA-N cardol Chemical compound CCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 KVVSCMOUFCNCGX-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 229940080237 sodium caseinate Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- JOLVYUIAMRUBRK-UHFFFAOYSA-N 11',12',14',15'-Tetradehydro(Z,Z-)-3-(8-Pentadecenyl)phenol Natural products OC1=CC=CC(CCCCCCCC=CCC=CCC=C)=C1 JOLVYUIAMRUBRK-UHFFFAOYSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- YLKVIMNNMLKUGJ-UHFFFAOYSA-N 3-Delta8-pentadecenylphenol Natural products CCCCCCC=CCCCCCCCC1=CC=CC(O)=C1 YLKVIMNNMLKUGJ-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 235000001274 Anacardium occidentale Nutrition 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- JOLVYUIAMRUBRK-UTOQUPLUSA-N Cardanol Chemical compound OC1=CC=CC(CCCCCCC\C=C/C\C=C/CC=C)=C1 JOLVYUIAMRUBRK-UTOQUPLUSA-N 0.000 description 1
- FAYVLNWNMNHXGA-UHFFFAOYSA-N Cardanoldiene Natural products CCCC=CCC=CCCCCCCCC1=CC=CC(O)=C1 FAYVLNWNMNHXGA-UHFFFAOYSA-N 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004470 DL Methionine Substances 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 239000004258 Ethoxyquin Substances 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000309145 Pseudomonas aeruginosa DSM 50071 = NBRC 12689 Species 0.000 description 1
- 241000221037 Pyrularia pubera Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 241000194021 Streptococcus suis Species 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 239000004330 calcium propionate Substances 0.000 description 1
- 235000010331 calcium propionate Nutrition 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- PTFIPECGHSYQNR-UHFFFAOYSA-N cardanol Natural products CCCCCCCCCCCCCCCC1=CC=CC(O)=C1 PTFIPECGHSYQNR-UHFFFAOYSA-N 0.000 description 1
- UFMJCOLGRWKUKO-UHFFFAOYSA-N cardol diene Natural products CCCC=CCC=CCCCCCCCC1=CC(O)=CC(O)=C1 UFMJCOLGRWKUKO-UHFFFAOYSA-N 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 229950010030 dl-alanine Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 1
- 235000019285 ethoxyquin Nutrition 0.000 description 1
- 229940093500 ethoxyquin Drugs 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Food Science & Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Description
鼓脹症は第一胃内容液が泡沫状になることでガスと液が分離しなくなり、たまったガスをあい気で外に出せなくなった状態であり、心臓と肺を圧迫し、そのままだと死んでしまう。粗飼料が少なく、トウモロコシなどのデンプン質の多く含まれるエサを与えると、ルーメン内でStreptococcus bovisが増え、産生された粘性物質のためルーメン液が泡沫状になる。
また、カシューナッツ殻油がStaphylococcos aureus、Streptococcus mutans、Bacillus subtilis、Bacillus ammoniagenesのようなグラム陽性菌に抗菌作用があり、Escherichia coli、Enterobacter aerogenes、Pseudomonas aeruginosaのようなグラム陰性菌およびSaccharomyces cerevisiae、Candida utilis、Penichillium chrysogenumのような真菌に抗菌作用が無いことが報告されているが(非特許文献2)、カシューナッツ殻油のS.bovisに対する抗菌作用は知られておらず、鼓脹症予防効果に関しては報告が全く無い。
(1)カシューナッツ殻油を含有することを特徴とする反芻動物の鼓脹症防除剤。
(2)鼓脹症がStreptococcus bovisにより引き起こされる、(1)に記載の鼓脹症防除剤。
(3)(1)または(2)記載の鼓脹症防除剤を含有することを特徴とする、鼓脹症防除用飼料用組成物。
(4)(3)記載の飼料用組成物を含有することを特徴とする、鼓脹症防除用飼料。
(5)カシューナッツ殻油を含有することを特徴とする鼓脹症防除用飼料用組成物。
(6)カシューナッツ殻油を含有することを特徴とする鼓脹症防除用飼料。
(7)カシューナッツ殻油を反芻動物に投与することを特徴とする反芻動物の鼓脹症の防除方法。
(8)反芻動物の鼓脹症防除剤の製造におけるカシューナッツ殻油の使用。
(9)鼓脹症防除用飼料用組成物の製造におけるカシューナッツ殻油の使用。
(10)鼓脹症防除用飼料の製造におけるカシューナッツ殻油の使用。
本発明において使用されるカシューナッツ殻油は、その他にも加熱殺菌処理油、カシューナッツの殻を粉砕・破砕して得られたものであってもよい。
本発明において使用されるカシューナッツ殻油は、市販品を用いることもできる。
本発明における鼓脹症は、マメ科牧草や濃厚飼料によって引き起こされる鼓脹症をも含むものであり、本発明の鼓脹症防除剤は、このような鼓脹症に対しても効果を有するものである。
本発明の鼓脹症防除剤を飼料用組成物として用いる場合は、ペットフード、ペット用サプリメント(以下、飼料という。)に用いられる他の飼料成分と混合して、飼料とすることができる。飼料の種類や、カシューナッツ殻油以外の成分は、特に制限されない。
なお、本発明の飼料におけるカシューナッツ殻油の含有量は、飼料の乾物質量当たり、効果やコストの面から、0.5〜50,000質量ppmが好ましく、より好ましくは5〜10,000質量ppm、さらに好ましくは50〜5,000質量ppmである。
飼料を摂取させる方法及び飼育する方法は、動物の種類に応じて、通常用いられる方法をとることができる。
S.bovisに対するCNSLの抗菌作用
カシュー・トレーディング(株)より、カシューナッツの殻から圧搾で抽出したカシューナッツ殻油(CNSL)を入手した。
CNSLの抗菌作用を調べるため、Staphylococcos aureus牛分離菌株、S.bovis DSM20065株、Bacillus subtilis NBRC3009株、Escherichia coli ATCC11303株、Pseudomonas aeruginosa NBRC12689株、およびSaccharomyces cerevisiae NBRC10217株をブレインハートインフュージョン培地(日水製薬(株)製品)で37℃1日培養した。CNSLを添加したブレインハートインフュージョン培地に、前記した各々の菌株の培養液を10μL植菌し、37℃で2日間培養し最小生育阻止濃度(MIC)を算出した。
結果を表1に示す。
CNSL投与のインビボでの経時的な影響
(1)試料
ルーメンカニューレを装着しためん羊4頭に、体重の1.4質量%相当の餌(濃厚飼料:乾草=3:7(体積))を給与した。
CNSL投与開始前に一回目のルーメン内容物のサンプリングを行った。CNSL投与量は、これまでのin vitro試験で100mg/L以上でルーメン機能改善効果が認められた。羊のルーメン液中で100mg/Lにするためには、ルーメン液中で希釈されることから、餌に0.14〜0.28質量%(1,400〜2,800質量ppm)混合する必要が有る。そこで、初めの2週間は餌にCNSLを0.14質量%給与し、1週間毎2回ルーメン内容物のサンプリングを行った。次の2週間は餌にCNSLを0.28質量%給与し、1週間毎2回ルーメン内容物のサンプリングを行った。次の2週間はCNSLを無投与で餌のみ給与し、1週間毎2回ルーメン内容物のサンプリングを行った。
(2)結果
ルーメン液のpHを表2に示す。
ルーメン液の粘度(CP)、ルーメン液の起泡性(IVI(%))および泡沫安定性(sIVI(%))を表3に示す。
Claims (7)
- カシューナッツ殻油および/またはアナカルド酸を含有することを特徴とする、反芻動物の、Streptococcus bovisにより引き起こされる鼓脹症防除剤またはアシドーシス防除剤。
- カシューナッツ殻油および/またはアナカルド酸を含有することを特徴とする、反芻動物の、Streptococcus bovisにより引き起こされる鼓脹症またはアシドーシス防除用飼料用の組成物。
- カシューナッツ殻油および/またはアナカルド酸を含有することを特徴とする、反芻動物の飼料用の組成物(コクシジウム症軽減用の飼料用組成物を除く)。
- カシューナッツ殻油および/またはアナカルド酸を含有することを特徴とする、Streptococcus bovisにより引き起こされる鼓脹症防除用またはアシドーシス防除用飼料。
- カシューナッツ殻油および/またはアナカルド酸を含有することを特徴とする、反芻動物用飼料(コクシジウム症軽減用の飼料を除く)。
- カシューナッツ殻油および/またはアナカルド酸を反芻動物に投与することを特徴とする、反芻動物の、Streptococcus bovisにより引き起こされる鼓脹症またはアシドーシスの防除方法。
- カシューナッツ殻油および/またはアナカルド酸を配合することを特徴とする、反芻動物の、Streptococcus bovisにより引き起こされる鼓脹症防除剤またはアシドーシス防除剤の製造方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009517919A JP5424401B2 (ja) | 2007-06-08 | 2008-06-06 | 反芻動物の鼓脹症防除剤 |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007153285 | 2007-06-08 | ||
JP2007153285 | 2007-06-08 | ||
JP2008029494 | 2008-02-08 | ||
JP2008029494 | 2008-02-08 | ||
PCT/JP2008/060492 WO2008149994A1 (ja) | 2007-06-08 | 2008-06-06 | 反芻動物の鼓脹症防除剤 |
JP2009517919A JP5424401B2 (ja) | 2007-06-08 | 2008-06-06 | 反芻動物の鼓脹症防除剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2008149994A1 JPWO2008149994A1 (ja) | 2010-08-26 |
JP5424401B2 true JP5424401B2 (ja) | 2014-02-26 |
Family
ID=40093797
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009517917A Withdrawn JPWO2008149992A1 (ja) | 2007-06-08 | 2008-06-06 | ルーメン発酵改善剤 |
JP2009517919A Active JP5424401B2 (ja) | 2007-06-08 | 2008-06-06 | 反芻動物の鼓脹症防除剤 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009517917A Withdrawn JPWO2008149992A1 (ja) | 2007-06-08 | 2008-06-06 | ルーメン発酵改善剤 |
Country Status (14)
Country | Link |
---|---|
US (2) | US8349370B2 (ja) |
EP (2) | EP2165609B1 (ja) |
JP (2) | JPWO2008149992A1 (ja) |
KR (2) | KR101486611B1 (ja) |
CN (2) | CN101677596A (ja) |
AU (2) | AU2008260900B2 (ja) |
BR (2) | BRPI0812884A2 (ja) |
CA (2) | CA2689641C (ja) |
CO (2) | CO6150099A2 (ja) |
DK (1) | DK2165610T3 (ja) |
ES (2) | ES2406423T3 (ja) |
NZ (2) | NZ581527A (ja) |
RU (2) | RU2009149163A (ja) |
WO (2) | WO2008149992A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5484340B2 (ja) * | 2008-09-29 | 2014-05-07 | 出光興産株式会社 | 反芻動物の鼓脹症治療剤 |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR074190A1 (es) * | 2008-11-04 | 2010-12-29 | Idemitsu Kosan Co | Agente controlador de la acidosis para un rumiante. composicion. metodo. pienso. uso. |
EP2397147B1 (en) * | 2008-12-12 | 2015-06-03 | Idemitsu Kosan Co., Ltd. | Feed for preventing and/or treating diseases caused by clostridium bacterium in livestock, and agent against clostridium |
WO2010071222A1 (ja) * | 2008-12-20 | 2010-06-24 | 味の素株式会社 | 反芻動物用メタン生成抑制剤および飼料組成物 |
WO2011013592A1 (ja) * | 2009-07-30 | 2011-02-03 | 出光興産株式会社 | コート製剤 |
BR112012030643B1 (pt) * | 2010-06-03 | 2021-07-20 | Idemitsu Kosan Co., Ltd | Método de inibição da reação de descarboxilação de um ácido anacárdico em um líquido de casca de castanha de caju não aquecida |
FR2966603B1 (fr) * | 2010-10-21 | 2012-11-16 | Valorex Sa | Procede d'evaluation de la quantite de methane produite par un ruminant laitier |
KR20130099169A (ko) * | 2010-11-05 | 2013-09-05 | 이데미쓰 고산 가부시키가이샤 | 안정성이 향상된 캐슈 너트셸 오일 |
DK2661969T3 (en) | 2011-01-07 | 2018-10-29 | Idemitsu Kosan Co | Means to improve milk yield and / or milk quality for ruminants |
AU2016204291B2 (en) * | 2011-01-07 | 2016-12-22 | Sds Biotech K.K. | Agent for improving milk yield and/or milk quality of ruminants, preventive or therapeutic agent for perinatal disease, and agent for improving reproductive efficiency |
US20130224320A1 (en) * | 2012-02-23 | 2013-08-29 | Joan Torrent Campmany | Process to improve feed efficiency and carcass characteristics of animals |
WO2015121220A1 (en) * | 2014-02-14 | 2015-08-20 | Gea Farm Technologies Gmbh | Method and apparatus for monitoring nutrition, especially fermentation in a rumen of a ruminant |
CA2968653C (en) | 2014-11-26 | 2023-01-03 | River Road Research, Inc. | Method for converting food waste and other biological waste into invertebrate feed |
CN106387353A (zh) * | 2016-08-31 | 2017-02-15 | 广州市义和化工有限公司 | 一种饲料用组合物及其制造方法 |
AR120346A1 (es) | 2019-10-31 | 2022-02-09 | Idemitsu Kosan Co | Agente para suprimir la resistencia a la insulina en rumiantes |
JP7519661B2 (ja) | 2019-12-03 | 2024-07-22 | 株式会社エス・ディー・エス バイオテック | 腸管細胞の炎症抑制剤 |
EP4349357A1 (en) | 2021-05-28 | 2024-04-10 | Sds Biotech K.K. | Anti-inflammatory agent for intestinal cells of domestic animal |
WO2024075706A1 (ja) * | 2022-10-03 | 2024-04-11 | 株式会社エス・ディー・エス バイオテック | 反芻動物のメタン産生抑制剤 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08231410A (ja) * | 1995-02-23 | 1996-09-10 | Takasago Internatl Corp | コクシジウム症軽減剤及びそれを含有する飼料 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2317611A (en) * | 1939-12-07 | 1943-04-27 | Harvel Corp | Cashew nut shell liquid material compositions and bases carrying the same |
JPH0781137B2 (ja) | 1990-01-24 | 1995-08-30 | 御木本製薬株式会社 | 酸化防止剤 |
JP3217484B2 (ja) | 1992-08-17 | 2001-10-09 | 株式会社リコー | 高耐圧半導体装置 |
JP4680339B2 (ja) * | 1999-11-26 | 2011-05-11 | 日清丸紅飼料株式会社 | コクシジウム症の予防および/または治療用飼料 |
JP4783512B2 (ja) * | 2001-03-27 | 2011-09-28 | 社団法人農林水産先端技術産業振興センター | 反芻動物のメタン生成を抑制する飼料組成物 |
SE0400996D0 (sv) * | 2004-04-16 | 2004-04-16 | Alltech Ireland Inc | Use of plants, plant extracts and nature-identical components from plants to affect the rumen fermentation and to improve the energy and protein retention of ruminants |
JP2006166853A (ja) * | 2004-12-17 | 2006-06-29 | Ajinomoto Co Inc | 反芻動物用のメタン生成抑制剤および飼料組成物 |
-
2008
- 2008-06-06 NZ NZ581527A patent/NZ581527A/en unknown
- 2008-06-06 AU AU2008260900A patent/AU2008260900B2/en active Active
- 2008-06-06 US US12/663,598 patent/US8349370B2/en active Active
- 2008-06-06 JP JP2009517917A patent/JPWO2008149992A1/ja not_active Withdrawn
- 2008-06-06 EP EP08777110.1A patent/EP2165609B1/en active Active
- 2008-06-06 CA CA2689641A patent/CA2689641C/en active Active
- 2008-06-06 NZ NZ581528A patent/NZ581528A/en unknown
- 2008-06-06 WO PCT/JP2008/060490 patent/WO2008149992A1/ja active Application Filing
- 2008-06-06 DK DK08777112.7T patent/DK2165610T3/da active
- 2008-06-06 RU RU2009149163/13A patent/RU2009149163A/ru not_active Application Discontinuation
- 2008-06-06 WO PCT/JP2008/060492 patent/WO2008149994A1/ja active Application Filing
- 2008-06-06 CN CN200880019242A patent/CN101677596A/zh active Pending
- 2008-06-06 ES ES08777112T patent/ES2406423T3/es active Active
- 2008-06-06 KR KR1020107000182A patent/KR101486611B1/ko active IP Right Grant
- 2008-06-06 CN CN200880019243A patent/CN101677597A/zh active Pending
- 2008-06-06 AU AU2008260898A patent/AU2008260898B2/en active Active
- 2008-06-06 JP JP2009517919A patent/JP5424401B2/ja active Active
- 2008-06-06 BR BRPI0812884-7A2A patent/BRPI0812884A2/pt not_active IP Right Cessation
- 2008-06-06 ES ES08777110.1T patent/ES2444442T3/es active Active
- 2008-06-06 RU RU2009149164/13A patent/RU2009149164A/ru not_active Application Discontinuation
- 2008-06-06 US US12/663,607 patent/US20100183756A1/en not_active Abandoned
- 2008-06-06 EP EP08777112A patent/EP2165610B1/en active Active
- 2008-06-06 CA CA2689604A patent/CA2689604A1/en not_active Abandoned
- 2008-06-06 BR BRPI0812886-3A patent/BRPI0812886B1/pt active IP Right Grant
- 2008-06-06 KR KR1020107000383A patent/KR101477840B1/ko active IP Right Grant
-
2009
- 2009-12-15 CO CO09143516A patent/CO6150099A2/es unknown
- 2009-12-15 CO CO09143515A patent/CO6150098A2/es unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08231410A (ja) * | 1995-02-23 | 1996-09-10 | Takasago Internatl Corp | コクシジウム症軽減剤及びそれを含有する飼料 |
Non-Patent Citations (2)
Title |
---|
JPN6012064476; 'A review of bloat in feedlot cattle.' Journal of Animal Science Vol.76, Issue 1, 1998, 299-308 * |
JPN6012064478; 'Antibacterial agents from the cashew Anacardium occidentale (Anacardiaceae) nut shell oil' Journal of Agricultural Food Chemistry Vol.39, 1991, 418-421 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5484340B2 (ja) * | 2008-09-29 | 2014-05-07 | 出光興産株式会社 | 反芻動物の鼓脹症治療剤 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5424401B2 (ja) | 反芻動物の鼓脹症防除剤 | |
JP5502754B2 (ja) | 家畜のクロストリディウム属細菌による疾病の予防及び/又は治療用飼料、並びに抗クロストリディウム剤 | |
JP5634261B2 (ja) | 飼料用組成物およびそれを含有する飼料 | |
CA2556392C (en) | Feeds containing hop acids and uses thereof as supplements in animal feeds | |
WO2010143627A1 (ja) | コクシジウム症防除剤およびそれを含有する飼料 | |
JP5484340B2 (ja) | 反芻動物の鼓脹症治療剤 | |
JPWO2009139468A1 (ja) | コクシジウム症防除剤およびそれを含有する飼料 | |
JPWO2010053085A1 (ja) | 反芻動物のアシドーシス防除剤 | |
WO2015056729A1 (ja) | 機能性飼料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20100804 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110602 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110602 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121211 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130207 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131029 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131122 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5424401 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |